Release Date: 04/12/17 16:16 Summary: Bidders Statement - Market bid Price Sensitive: No Download Document 1.01MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%